C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/7.1, 530/7.3
C07K 14/575 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1247605
CRF ANALOGS ABSTRACT OF THE DISCLOSURE Analogs of rCRF and oCRF are disclosed that can be administered to achieve a substantial elevation of ACTH, .beta.-endorphin, B-lipotropin, other products of the pro-opiomelanocortin gene and corticosterone levels and/or a lowering of blood pressure over an extended period of time. One analog which has been found to be particularly potent is: Image . In the analogs, one or more of the first five N-terminal residues may be deleted or may be substituted by a peptide up to 10 amino acids long and/or by an acylating agent containing up to 7 carbon atoms. A number of other substitutions may also be made throughout the chain. These analogs or pharmaceutically or veterinarily acceptable salts thereof, dispersed in a pharmaceutically or veterinarily acceptable liquid or solid carrier, can be administered to mammals, including humans. These analogs may also be used as stimulants to elevate mood and improve memory and learning, as well as diagnostically.
477389
Rivier Jean E.f.
Vale Wylie W. Jr.
Macrae & Co.
Salk Institute For Biological Studies (the)
LandOfFree
Crf analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crf analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crf analogs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1335176